These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37821203)

  • 1. Targeted Treatment of Diseases of Immune Dysregulation.
    Mohan S
    Rheum Dis Clin North Am; 2023 Nov; 49(4):913-929. PubMed ID: 37821203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologics and JAK inhibitors for the treatment of monogenic systemic autoinflammatory diseases in children.
    Du Y; Liu M; Nigrovic PA; Dedeoglu F; Lee PY
    J Allergy Clin Immunol; 2023 Mar; 151(3):607-618. PubMed ID: 36707349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary Autoinflammatory Disorders: Recognition and Treatment.
    Broderick L
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):13-29. PubMed ID: 30466770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Innate immunity, autoimmunity and autoinflammation].
    Bendtzen K
    Ugeskr Laeger; 2011 Sep; 173(38):2337-40. PubMed ID: 21936976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment.
    Havnaer A; Han G
    Am J Clin Dermatol; 2019 Aug; 20(4):539-564. PubMed ID: 30997665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK inhibition in the type I interferonopathies.
    Crow YJ; Neven B; Frémond ML
    J Allergy Clin Immunol; 2021 Oct; 148(4):991-993. PubMed ID: 34375617
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulating against the dysregulation: new treatment options in autoinflammation.
    Kallinich T
    Semin Immunopathol; 2015 Jul; 37(4):429-37. PubMed ID: 26059720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoinflammation: Interferonopathies and Other Autoinflammatory Diseases.
    Savic S; Coe J; Laws P
    J Invest Dermatol; 2022 Mar; 142(3 Pt B):781-792. PubMed ID: 34887082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception of self: distinguishing autoimmunity from autoinflammation.
    van Kempen TS; Wenink MH; Leijten EF; Radstake TR; Boes M
    Nat Rev Rheumatol; 2015 Aug; 11(8):483-92. PubMed ID: 25963881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting cytokines to treat autoinflammatory diseases.
    Hausmann JS
    Clin Immunol; 2019 Sep; 206():23-32. PubMed ID: 30394352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoinflammatory disorders, pain, and neural regulation of inflammation.
    Chen MC; Meckfessel MH
    Dermatol Clin; 2013 Jul; 31(3):461-70. PubMed ID: 23827248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoinflammatory diseases: update on classification diagnosis and management.
    Pathak S; McDermott MF; Savic S
    J Clin Pathol; 2017 Jan; 70(1):1-8. PubMed ID: 27646526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience of Autoimmune and autoinflammatory diseases in a Turkish pediatric cohort with primary immunodeficiencies.
    Özcan D; Serbes M; Ekinci RMK; Çetinkaya SB; Şaşihüseyinoğlu AŞ; Bişgin A; Altıntaş DU
    Allergol Immunopathol (Madr); 2021; 49(6):1-7. PubMed ID: 34761650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is hiden behind autoinflammation?
    Hrubišková K; Jeseňák M; Payer J
    Vnitr Lek; 2020; 66(3):35-43. PubMed ID: 32972163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of cytokines to help establish diagnosis and guide treatment of autoinflammatory and autoimmune diseases.
    Chetaille Nézondet AL; Poubelle PE; Pelletier M
    J Leukoc Biol; 2020 Aug; 108(2):647-657. PubMed ID: 32040246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AutoCore: A network-based definition of the core module of human autoimmunity and autoinflammation.
    Guthrie J; Köstel Bal S; Lombardo SD; Müller F; Sin C; Hütter CVR; Menche J; Boztug K
    Sci Adv; 2023 Sep; 9(35):eadg6375. PubMed ID: 37656781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trained Immunity Contribution to Autoimmune and Inflammatory Disorders.
    Funes SC; Rios M; Fernández-Fierro A; Di Genaro MS; Kalergis AM
    Front Immunol; 2022; 13():868343. PubMed ID: 35464438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (
    Grandemange S; Sanchez E; Louis-Plence P; Tran Mau-Them F; Bessis D; Coubes C; Frouin E; Seyger M; Girard M; Puechberty J; Costes V; Rodière M; Carbasse A; Jeziorski E; Portales P; Sarrabay G; Mondain M; Jorgensen C; Apparailly F; Hoppenreijs E; Touitou I; Geneviève D
    Ann Rheum Dis; 2017 Jul; 76(7):1191-1198. PubMed ID: 27965258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of autoinflammatory syndromes.
    Hoffman HM
    J Allergy Clin Immunol; 2009 Dec; 124(6):1129-38; quiz 1139-40. PubMed ID: 20004774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.